Literature DB >> 27992658

Antimicrobial activity of Manuka honey against antibiotic-resistant strains of the cell wall-free bacteria Ureaplasma parvum and Ureaplasma urealyticum.

K L Hillitt1, R E Jenkins1, O B Spiller2, M L Beeton1.   

Abstract

The susceptibility of the cell wall-free bacterial pathogens Ureaplasma spp. to Manuka honey was examined. The minimum inhibitory concentration (MIC) of Manuka honey for four Ureaplasma urealyticum and four Ureaplasma parvum isolates was determined. Sensitivity to honey was also compared to clinical isolates with resistance to tetracycline, macrolide and fluoroquinolone antibiotics. Finally step-wise resistance training was utilized in an attempt to induce increased tolerance to honey. The MIC was dependent on the initial bacterial load with 7·5 and 18·0% w/v honey required to inhibit U. urealyticum at 1 and 106 colour changing units (CCU), respectively, and 4·8 and 15·3% w/v required to inhibit U. parvum at 1 and 106  CCU respectively. MIC values were consistently lower for U. parvum compared with U. urealyticum. Antimicrobial activity was seen against tetracycline-resistant, erythromycin-resistant and ciprofloxacin-resistant isolates at 105  CCU. No resistance to honey was observed with 50 consecutive challenges at increasing concentrations of honey. This is the first report of the antimicrobial activity of Manuka honey against a cell wall-free bacterial pathogen. The antimicrobial activity was retained against antibiotic-resistant strains and it was not possible to generate resistant mutants. SIGNIFICANCE AND IMPACT OF THE STUDY: Manuka honey is known to have a broad spectrum of antimicrobial activity, with the bacterial cell wall being suggested as a predominant site of action. This study has demonstrated that Manuka honey has activity against Ureaplasma spp., a genus of cell wall-free bacteria which are intrinsically resistant to many available antibiotics making treatment inherently difficult. This is the first report of the antimicrobial activity of Manuka honey against a bacterial pathogen, in the absence of a cell well and opens scope for the use of components of Manuka honey as a therapeutic among Ureaplasma infections.
© 2016 The Society for Applied Microbiology.

Entities:  

Keywords:  antimicrobials; infection; microbial physiology; microbial structure; resistance

Mesh:

Substances:

Year:  2017        PMID: 27992658     DOI: 10.1111/lam.12707

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  4 in total

1.  Manuka honey modulates the release profile of a dHL-60 neutrophil model under anti-inflammatory stimulation.

Authors:  Benjamin A Minden-Birkenmaier; Meghan B Meadows; Kasyap Cherukuri; Matthew P Smeltzer; Richard A Smith; Marko Z Radic; Gary L Bowlin
Journal:  J Tissue Viability       Date:  2020-03-26       Impact factor: 2.932

2.  Evolution of honey resistance in experimental populations of bacteria depends on the type of honey and has no major side effects for antibiotic susceptibility.

Authors:  Anna M Bischofberger; Katia R Pfrunder Cardozo; Michael Baumgartner; Alex R Hall
Journal:  Evol Appl       Date:  2021-03-10       Impact factor: 5.183

Review 3.  Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation.

Authors:  Callum J Cooper; Shazeeda Koonjan; Anders S Nilsson
Journal:  Pharmaceuticals (Basel)       Date:  2018-04-19

4.  Antibacterial and antioxidant activity of different types of honey derived from Mount Olympus in Greece.

Authors:  Dimitrios Stagos; Nikolaos Soulitsiotis; Christina Tsadila; Stamatina Papaeconomou; Charalampos Arvanitis; Alexandros Ntontos; Fani Karkanta; Soultana Adamou-Androulaki; Konstantinos Petrotos; Demetrios A Spandidos; Demetrios Kouretas; Dimitris Mossialos
Journal:  Int J Mol Med       Date:  2018-05-04       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.